Atrial fibrillation in heart failure: Catheter and surgical interventional therapies

Heart Failure Reviews

Volumn 19, Issue 3, 2014, Pages 325-330

  Rabah, Ali ^a   Wazni, Oussama ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atrial fibrillation; Atrial fibrillation ablation; AV node ablation; Heart failure; Maze; Rate control; Rhythm; Rhythm control

Indexed keywords

AMIODARONE; DOFETILIDE; ANTIARRHYTHMIC AGENT;

ABLATION THERAPY; AORTOESOPHAGEAL FISTULA; ARTICLE; CARDIOVASCULAR DISEASE; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; DEATH; ESOPHAGUS INJURY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART PACING; HEART TAMPONADE; HUMAN; INTERMETHOD COMPARISON; MITRAL VALVE; PHRENIC NERVE; PULMONARY VEIN ISOLATION; PULMONARY VEIN OBSTRUCTION; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; SINUS RHYTHM; TREATMENT RESPONSE; ATRIAL FIBRILLATION; COMPARATIVE EFFECTIVENESS; COMPLICATION; HEART RATE; HEART SURGERY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROCEDURES; THROMBOEMBOLISM;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CARDIAC SURGICAL PROCEDURES; CATHETER ABLATION; COMPARATIVE EFFECTIVENESS RESEARCH; HEART FAILURE; HEART RATE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); THROMBOEMBOLISM;

EID: 84898919752     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-013-9411-x     Document Type: Article

References (50)

1. Lloyd-Jones D et al (2009) Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:e21-e181
2. Lloyd-Jones DM et al (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110:1042-1046
3. Lloyd-Jones D et al (2010) Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121:e46-e215
4. Lloyd-Jones DM et al (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106:3068-3072
5. Khand AU, Rankin AC, Kaye GC, Cleland JG (2000) Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 21:614-632
6. Benjamin EJ et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA, J Am Med Assoc 271:840-844
7. Eijsbouts SCM, Majidi M, Van Zandvoort M, Allessie MA (2003) Effects of acute atrial dilation on heterogeneity in conduction in the isolated rabbit heart. J Cardiovasc Electrophysiol 14:269-278
8. Kalifa J et al (2003) Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 108:668-671
9. Li D et al (2001) Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104:2608-2614
10. Dries DL et al (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventric. J Am Coll Cardiol 32:695-703
11. Olsson LG et al (2006) Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 47:1997-2004
12. Crijns HJ et al (2000) Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 21:1238-1245
13. Carson PE et al. (1993) The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 87, VI102-10
14. Shinbane JS et al (1997) Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 29:709-715
15. Clark DM, Plumb VJ, Epstein AE, Kay GN (1997) Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 30:1039-1045
16. Wyse DG et al (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-1833
17. Van Gelder IC et al (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834-1840
18. Corley SD et al (2004) Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109:1509-1513
19. Deedwania PC et al (1998) Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department. Circulation 98:2574-2579
20. Pedersen OD et al (2003) Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study. Card Electrophysiol Rev 7:220-224
21. Hagens VE et al (2005) Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study. Heart Rhythm: Off J Heart Rhythm Soc 2:19-24
22. Roy D et al (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667-2677
23. Bardy GH et al (2005) Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. N Engl J Med 352:225-237
24. Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA (2000) Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 101:1138-1144
25. Wilkoff BL et al (2002) Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA, J Am Med Assoc 288:3115-3123
26. Doshi RN et al (2005) Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 16:1160-1165
27. Stavrakis S, Garabelli P, Reynolds DW (2012) Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis. Europace: Eur Pacing, Arrhythm, Card Electrophysiol: J Work Groups Card Pacing, Arrhythm, Card Cell Electrophysiol Eur Soc Cardiol 14:1490-1497
28. Khan MN et al (2008) Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 359:1778-1785
29. Haïssaguerre M et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659-666
30. Jalife J (2003) Rotors and spiral waves in atrial fibrillation. J Cardiovasc Electrophysiol 14:776-780
31. Haïssaguerre M et al (2005) Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 16:1138-1147
32. Wazni OM et al (2005) Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA, J Am Med Assoc 293:2634-2640
33. Pappone C et al (2006) A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 48:2340-2347
34. Noheria A, Kumar A, Wylie JV, Josephson ME (2008) Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch Intern Med 168:581-586
35. Cappato R et al (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3:32-38
36. Chen MS et al (2004) Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 43:1004-1009
37. Hsu L-F et al (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373-2383
38. De Potter T et al (2010) Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace: Eur Pacing, Arrhythm, Card Electrophysiol: J Work Groups Card Pacing, Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 12:24-29
39. Lutomsky BA et al (2008) Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace: Eur Pacing, Arrhyth, Card Electrophysiol: J Work Groups Card Pacing, Arrhythm, Card Cell Electrophysiol Eur Soc Cardiol 10:593-599
40. MacDonald MR et al (2011) Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart (Br Card Soc) 97:740-747
41. Dagres N et al (2011) Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis. J Card Fail 17:964-970
42. Jones DG et al (2013) A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol 61:1894-1903
43. Swank AM et al (2012) Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training. Circ Heart Fail 5:579-585
44. Marrouche NF, Brachmann J (2009) Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - study design. Pacing Clin Electrophysiol: PACE 32:987-994
45. Grigioni F et al (2002) Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 40:84-92
46. Quader MA et al (2004) Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann Thorac Surg 77:1514-1522 discussion 1522-1524
47. Rabkin DG et al (2004) Load dependence of cardiac output in biventricular pacing: right ventricular pressure overload in pigs. J Thorac Cardiovasc Surg 127:1713-1722
48. Gillinov AM et al (2005) The Cox maze procedure in mitral valve disease: predictors of recurrent atrial fibrillation. J Thorac Cardiovasc Surg 130:1653-1660
49. Stulak JM et al (2006) Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status. Ann Thorac Surg 82:494-500 discussion 500-1
50. Ad N, Henry L, Hunt S (2011) The impact of surgical ablation in patients with low ejection fraction, heart failure, and atrial fibrillation. Eur J Cardio-Thorac Surg: Off J Eur Assoc Cardio-Thorac Surg 40:70-76